These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37241131)

  • 1. Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction.
    Tsuji M; Maki S; Enomoto N; Okamoto K; Kitamura A; Magawa S; Takakura S; Nii M; Tanaka K; Yodoya N; Tanaka H; Sawada H; Kondo E; Hirayama M; Ikeda T
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241131
    [No Abstract]   [Full Text] [Related]  

  • 2. Femur-sparing pattern of abnormal fetal growth in pregnant women from New York City after maternal Zika virus infection.
    Walker CL; Merriam AA; Ohuma EO; Dighe MK; Gale M; Rajagopal L; Papageorghiou AT; Gyamfi-Bannerman C; Adams Waldorf KM
    Am J Obstet Gynecol; 2018 Aug; 219(2):187.e1-187.e20. PubMed ID: 29738748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of femur length leads to underestimation of fetal weight in asymmetric preterm growth restriction.
    Proctor LK; Rushworth V; Shah PS; Keunen J; Windrim R; Ryan G; Kingdom J
    Ultrasound Obstet Gynecol; 2010 Apr; 35(4):442-8. PubMed ID: 20196066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitions matter: detection rates and perinatal outcome for infants classified prenatally as having late fetal growth restriction using SMFM biometric vs ISUOG/Delphi consensus criteria.
    Schreiber V; Hurst C; da Silva Costa F; Stoke R; Turner J; Kumar S
    Ultrasound Obstet Gynecol; 2023 Mar; 61(3):377-385. PubMed ID: 35866888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report.
    Sakamoto M; Osato K; Kubo M; Nii M; Tanaka H; Murabayashi N; Umekawa T; Kamimoto Y; Ikeda T
    J Med Case Rep; 2016 Nov; 10(1):317. PubMed ID: 27821175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced fetal growth velocities and the association with neonatal outcomes in appropriate-for-gestational-age neonates: a retrospective cohort study.
    Hendrix MLE; van Kuijk SMJ; Gavilanes AWD; Kramer D; Spaanderman MEA; Al Nasiry S
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):31. PubMed ID: 30646865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced fetal growth velocity precedes antepartum fetal death.
    Pacora P; Romero R; Jung E; Gudicha DW; Hernandez-Andrade E; Musilova I; Kacerovsky M; Jaiman S; Erez O; Hsu CD; Tarca AL
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):942-952. PubMed ID: 32936481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth.
    Salomon LJ; Alfirevic Z; Da Silva Costa F; Deter RL; Figueras F; Ghi T; Glanc P; Khalil A; Lee W; Napolitano R; Papageorghiou A; Sotiriadis A; Stirnemann J; Toi A; Yeo G
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):715-723. PubMed ID: 31169958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of biometric measurement error on identification of small- and large-for-gestational-age fetuses.
    Wright D; Wright A; Smith E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):170-176. PubMed ID: 31682299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study on investigating the role of Salvia miltiorrhiza in fetal growth restriction.
    Shen F; Lv H; Shi Y; Lau S; Guo F; Chen Q
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32406912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
    Umekawa T; Maki S; Kubo M; Tanaka H; Nii M; Tanaka K; Osato K; Kamimoto Y; Tamaru S; Ogura T; Nishimura Y; Kodera M; Minamide C; Nishikawa M; Endoh M; Kimura T; Kotani T; Nakamura M; Sekizawa A; Ikeda T;
    BMJ Open; 2018 Oct; 8(10):e020948. PubMed ID: 30381311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International estimated fetal weight standards of the INTERGROWTH-21
    Stirnemann J; Villar J; Salomon LJ; Ohuma E; Ruyan P; Altman DG; Nosten F; Craik R; Munim S; Cheikh Ismail L; Barros FC; Lambert A; Norris S; Carvalho M; Jaffer YA; Noble JA; Bertino E; Gravett MG; Purwar M; Victora CG; Uauy R; Bhutta Z; Kennedy S; Papageorghiou AT;
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):478-486. PubMed ID: 27804212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction.
    Maki S; Kato I; Enomoto N; Takakura S; Nii M; Tanaka K; Tanaka H; Hori S; Matsuda K; Ueda Y; Sawada H; Hirayama M; Sudo A; Ikeda T
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32413997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
    Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal lobe development in fetuses with growth restriction by using ultrasound: a case-control study.
    Peng R; Zheng Q; Wu LH; Yin X; Zheng J; Xie HN
    BMC Pregnancy Childbirth; 2022 Nov; 22(1):861. PubMed ID: 36411456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental growth factor as a predictor of the efficacy of tadalafil treatment for fetal growth restriction.
    Kubo-Kaneda M; Tanaka H; Maki S; Nii M; Umekawa T; Osato K; Kamimoto Y; Kondo E; Ikeda T
    J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2879-2882. PubMed ID: 29580120
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasound prediction of adverse perinatal outcome at diagnosis of late-onset fetal growth restriction.
    Dall'Asta A; Stampalija T; Mecacci F; Minopoli M; Schera GBL; Cagninelli G; Ottaviani C; Fantasia I; Barbieri M; Lisi F; Simeone S; Ghi T; Frusca T
    Ultrasound Obstet Gynecol; 2022 Mar; 59(3):342-349. PubMed ID: 34159652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-Trimester Fetal Biometry and Neonatal Outcomes in Term and Preterm Deliveries.
    Sheth T; Glantz JC
    J Ultrasound Med; 2016 Jan; 35(1):103-10. PubMed ID: 26643756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal growth restriction with abnormal individual biometric parameters at second trimester ultrasound is associated with small for gestational age neonate at delivery.
    DeBolt CA; Sarker M; Cohen N; Kaplowitz E; Buckley A; Stone J; Bianco A
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():1-5. PubMed ID: 35276444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.